16 Feb 2025 | 10:00 AM - 10:40 AM
Davidson Ballroom A
16 Feb 2025 | 10:00 AM - 10:40 AM
Davidson Ballroom A


Ash Shehata, Rick Gundling, Azlan Tariq, Dr Soumi Saha
16 Feb 2025 | 10:45 AM - 11:20 AM
Davidson Ballroom A

Greg McDavitt, Pranay Gupta
16 Feb 2025 | 11:30 AM - 12:10 PM
Davidson Ballroom A



Alex Bohl, Dr Prabhjot Singh, Prof Patricia Mactaggart, Dr Michael Havig
16 Feb 2025 | 12:30 PM - 2:00 PM
Room 205ABC16 Feb 2025 | 12:30 PM - 2:30 PM
Room 201AB16 Feb 2025 | 1:00 PM - 1:40 PM
Davidson Ballroom A



Andrew Schwab, Narayana Murali, John Petito, Tricia McGinnis
16 Feb 2025 | 1:00 PM - 1:40 PM
Davidson Ballroom B/C



Bonnie Clipper, Allen Taylor, Tammy Cress, Dr Edtrina Moss, PhD, RN, MBA, NE-BC, AMB-BC, CLSSGB
16 Feb 2025 | 1:45 PM - 2:25 PM
Davidson Ballroom B/C

Dr Lori Wightman, Lavonia Thomas, Jing Wang, Lisa Gulker
16 Feb 2025 | 1:45 PM - 2:25 PM
Davidson Ballroom A



Pranam Ben, Jared Augenstein, Manmeet Kaur, Nate Paulsen
16 Feb 2025 | 2:30 PM - 3:10 PM
Davidson Ballroom B/C



Sherene Schlegel, KC Arnold, Dr Katie Boston-Leary, Dr Veronica Gillispie-Bell
16 Feb 2025 | 2:30 PM - 3:10 PM
Davidson Ballroom A



Cheryl Lulias, Dr Brent Asplin, Chris Caramanico, Erin Weber
16 Feb 2025 | 3:00 PM - 5:00 PM
Room 201AB

Create a free account or log in to unlock content, event past recordings and more!
Summary outlining the key points, main topics, and outcomes from the recorded session.













The healthcare M\&A landscape may be waking up from its nap in 2025. Private equity firms are poised to maintain their significant presence, having already acquired roughly 8% of private hospitals. Revenue cycle management, behavioral health, and digital health technologies remain prime targets for strategic consolidation, and health systems are continuing to reshape their hospital footprints. Innovative investment models like search funds and permanent capital vehicles are increasingly viewing healthcare as a stable, cash-flowing sector, signaling a sophisticated approach to industry investment. The potential shift in regulatory stance could further accelerate transactions, reducing antitrust scrutiny and making complex healthcare mergers more attractive.The focus is increasingly on value-driven consolidation that enhances operational effectiveness rather than pure transaction volume. We’re ready for some action!